Selectis Health, Inc.
Selectis Health, Inc. Fundamental Analysis
Selectis Health, Inc. (GBCS) shows moderate financial fundamentals with a PE ratio of 1.48, profit margin of 16.11%, and ROE of -1.37%. The company generates $0.0B in annual revenue with moderate year-over-year growth of 7.36%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -108.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze GBCS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentGBCS demonstrates superior asset utilization.
Valuation Score
ExcellentGBCS trades at attractive valuation levels.
Growth Score
ExcellentGBCS delivers strong and consistent growth momentum.
Financial Health Score
ModerateGBCS shows balanced financial health with some risks.
Profitability Score
WeakGBCS struggles to sustain strong margins.
Key Financial Metrics
Is GBCS Expensive or Cheap?
P/E Ratio
GBCS trades at 1.48 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, GBCS's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Selectis Health, Inc. at 35.26 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -0.67 times EBITDA. This is generally considered low.
How Well Does GBCS Make Money?
Net Profit Margin
For every $100 in sales, Selectis Health, Inc. keeps $16.11 as profit after all expenses.
Operating Margin
Core operations generate -6.29 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.37 in profit for every $100 of shareholder equity.
ROA
Selectis Health, Inc. generates $20.52 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Selectis Health, Inc. generates limited operating cash flow of $-1.44M, signaling weaker underlying cash strength.
Free Cash Flow
Selectis Health, Inc. generates weak or negative free cash flow of $-1.66M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.54 in free cash annually.
FCF Yield
GBCS converts -18.20% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
1.48
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.004
vs 25 benchmark
P/B Ratio
Price to book value ratio
35.26
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.24
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
66.59
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.53
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-1.37
vs 25 benchmark
ROA
Return on assets percentage
0.21
vs 25 benchmark
ROCE
Return on capital employed
-0.09
vs 25 benchmark
How GBCS Stacks Against Its Sector Peers
| Metric | GBCS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 1.48 | 29.38 | Better (Cheaper) |
| ROE | -136.86% | 739.00% | Weak |
| Net Margin | 16.11% | -53619.00% (disorted) | Strong |
| Debt/Equity | 66.59 | 0.39 | Weak (High Leverage) |
| Current Ratio | 2.53 | 4.03 | Strong Liquidity |
| ROA | 20.52% | -20116.00% (disorted) | Strong |
GBCS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Selectis Health, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
395.77%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-144.64%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
-282.66%
Industry Style: Defensive, Growth, Innovation
Declining